Now that the dust has settled post-ASH, I have had a chance to look over my notes and reflect back on the conference.
One of the most interesting story lines I discovered at ASH last month concerns bone marrow biopsy technology.
I found the industry to be a microcosm of our medical system in general–innovative, competitive and profit driven–a system where the best interest of the patient doesn’t always come first.
Please join me as I compare and contrast the corporate philosophies and technology of several prominent bone marrow biopsy delivery systems, starting Tuesday, January 11th. I’m excited to share my unexpected journey with all of my readers this week.
Feel good and keep smiling! Pat